For oncologists
Pembrolizumab.ai helps oncologists design better immunotherapy protocols using Pembrolizumab as a backbone. Explore new and custom regimens, compare them against your patient's biomarkers, and understand the protocol methodology and patient characteristics that contributed to response.
NEJM, The Lancet, J Clin Oncol, Nature Communications, ClinicalTrials.gov.
Side by side
Choose a cancer type, then select the regimens you want to weigh against each other. Their doses, methods, and outcomes line up side by side — with survival curves drawn on a single chart.
Contribute
Soon, oncologists will be able to add their own protocols — ones they're considering, actively running, or that a patient has completed — by hand or from a document.
Where is this protocol in its journey?
Upload a document to auto-fill, or enter details manually.
The sequence of what is given, in order.
Access
Published and public protocols are always free to browse and compare. Membership will unlock physician-contributed protocols and real patient outcomes — the data most useful for refining a regimen.
We're keeping the network small and highly vetted while it grows. Request an invitation below and we'll review it personally.
A few basics — we review every request by hand.
Membership is by invitation only. Tell us about your practice — we validate your NPI to keep the network peer-to-peer and review every request personally.